Predictive Analytics and Behavioral Nudges to Improve Palliative Care in Advanced Cancer

NACompletedINTERVENTIONAL
Enrollment

562

Participants

Timeline

Start Date

November 9, 2022

Primary Completion Date

June 13, 2023

Study Completion Date

October 3, 2023

Conditions
Cancer
Interventions
OTHER

EHR Nudge

Clinicians in Arm 1 (intervention) will receive a EHR notification with option to opt-out for palliative care referral for any eligible high-risk patient, defined by a risk score ≥1 for Stage IV cancer patients and ≥2 for Stage III cancer patients. If the risk score is above 8, they will be scheduled within 2 weeks, and all other patients will be scheduled within 4 weeks. Clinician will have the option to opt-out for any patient by responding to the notification which will be sent to the research coordinator. If the clinician does not respond, the research coordinator will approach patient via telephone, explain the rationale for referral based on a predetermined script, and offer and schedule an outpatient or telemedicine palliative care consultation per patient preference. Follow-up visits will occur at the discretion of the palliative care clinician, usually monthly.

Trial Locations (1)

37203

Tennessee Oncology, PLLC, Nashville

All Listed Sponsors
collaborator

Tennessee Oncology

OTHER

collaborator

Emerson Collective

UNKNOWN

lead

Abramson Cancer Center at Penn Medicine

OTHER